Buy
Sell
Share Name Share Symbol Market Type Share ISIN Share Description
Bioventix Plc LSE:BVXP London Ordinary Share GB00B4QVDF07 ORD 5P
  Price Change % Change Share Price Shares Traded Last Trade
  30.00 0.76% 3,980.00 1,182 16:35:00
Bid Price Offer Price High Price Low Price Open Price
3,900.00 3,980.00 3,985.00 3,940.00 3,940.00
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Pharmaceuticals & Biotechnology 10.31 8.23 139.41 28.5 207
Last Trade Time Trade Type Trade Size Trade Price Currency
16:35:00 UT 15 3,980.00 GBX

Bioventix (BVXP) Latest News

More Bioventix News
Bioventix Investors    Bioventix Takeover Rumours

Bioventix (BVXP) Discussions and Chat

Bioventix Forums and Chat

Date Time Title Posts
23/7/202116:30Bioventix - Sheep Antibodies1,345
08/11/201613:07ShareSoc Supper in Brighton-

Add a New Thread

Bioventix (BVXP) Most Recent Trades

No Trades
Trade Time Trade Price Trade Size Trade Value Trade Type
View all Bioventix trades in real-time

Bioventix (BVXP) Top Chat Posts

DateSubject
25/7/2021
09:20
Bioventix Daily Update: Bioventix Plc is listed in the Pharmaceuticals & Biotechnology sector of the London Stock Exchange with ticker BVXP. The last closing price for Bioventix was 3,950p.
Bioventix Plc has a 4 week average price of 3,820p and a 12 week average price of 3,820p.
The 1 year high share price is 4,500p while the 1 year low share price is currently 2,260p.
There are currently 5,209,333 shares in issue and the average daily traded volume is 5,604 shares. The market capitalisation of Bioventix Plc is £207,331,453.40.
21/7/2021
20:50
doctor888: Now it makes sense - Canaccord sold their holding down from 10% to 5% - wonder if they will keep selling? SP has kept looking at the support level of 3800/3850 - dodgy fractional share trading to inflate the close price for the past week or so, hiding the large sales during the day. That's my interpretation anyway - any differences of opinion?
16/7/2021
11:58
tomps2: John Rosier mentions Bioventix (BVXP) in the latest PIWORLD interview at 12m14s Watch the video here: Https://www.piworld.co.uk/education-videos/piworld-interview-john-rosiers-portfolio-update-july-2021/ Or listen to the podcast here: Https://piworld.podbean.com/e/piworld-interview-john-rosiers-portfolio-update-july-2021/
05/5/2021
09:07
scillyfool: Just read an interesting article on King’s College London’s work on a possible cure for migraine using monoclonal antibodies. No mention of who supplies the antibodies but may have to ask BVXP if they are involved. Apparently one billion people around the World suffer from migraines so this could be huge for whoever manufactures the antibodies. hxxps://www.kcl.ac.uk/news/professor-peter-goadsby-awarded-worlds-top-brain-prize-2021
04/5/2021
08:56
pob69: Blog posting profiling BVXP hTTps://www.musingmarkets.com/post/april-2021-u-k-stock-pick
29/3/2021
18:50
strollingmolby: Piedro, yes I initially thought there must be a mistake or exceptional adjustments made, but then recalled the last half-year results to Dec'19 were restated due to a sales rebate not being entered into the accounting system, a pretty silly mistake really and not clear how that could have happened. This is from the correction note on 31 March 2020: Correction - Unaudited Interim Results for the six months ended 31 December 2019 The Company has become aware that due to an administration error a sales rebate of $219k (£167k) was not entered into the accounting system. Consequently revenues for the six month period were £5.1m not the £5.3m as reported on 30 March 2020. Pre tax profits were £4.1m as opposed to £4.3m as previously stated. The cash figure and interim dividend remain unchanged. HTTPS://www.investegate.co.uk/bioventix-plc--bvxp-/prn/correction---interim-results/20200331174737P8321/
24/3/2021
08:48
altom: I am a new holder of BVXP. Pleasantly impressed by this thread. Sensible grown up chaps, golfers even, having a friendly chat. Some posters on other shares just mouth pointless obscenities. I also am a buy and hold investor rather than a trader. I seem to have bought this one at the wrong time, but I shall hang on and see what happens.
20/3/2021
13:34
housemartin2: Ha - yes spann_703, I am also a largely buy and hold investor. I too have mused about selling part of my holding with the intention of buying back on any weakness. In the end I decided against it, largely on the grounds that I have been pretty hopeless in both anticipating results and second guessing the market reaction to them in several cases recently. I also bought BVXP at an average of £8.06, have used up all my CGT allowance and so I would need a drop of almost £7 in the share price to make it worthwhile. Possible I know but just too much of a risk for me. (Yes also my second largest holding after BOTB !)
20/3/2021
13:15
spann_703: Housemartin2 as recent posts attest, I doubt you're the only one musing in such a fashion. I keep coming back to a line in the latest results; "we expect our business will revert to an established trajectory". To me this is foreshadowing a potential dip in the short-term, and I am wary about how the market will react to anything other than the usual growth from BVXP. Long-term I am still optimistic as to the company's prospects however. So eschewing my usual buy and hold strategy, I sold 50% of my holding over the past week. This is my second-largest holding behind BOTB, and I suspect what I am trying to do is mitigate some of the risk, and like APAD am looking to buy on any price weakness. I usually get these things wrong however, and the correct approach is probably to hold as usual. Interesting how long-term I think the company will do well, and yet devoid of any pressures I still sold half of my holding. Writing this down, it doesn't entirely seem like the rational thing to do; investing rationally is not always so easy.
20/3/2021
12:58
apad: I've been doing the same sort of speculating. At the current share price it takes 20 years of revenue to buy the company - an astoundingly high number. By comparison my other large holdings are: BOO is 3.2 years FEVR is 9 years TSTL is 9 years So, I too expect a setback on the results. BVXP is 16% of my portfolio, but I shall still buy more over 2021 if there is a decent price drop. GLA apad
27/1/2021
09:44
strollingmolby: David is welcome to continue posting such events on the thread as it is entirely relevant with BVXP being discussed there (this is why we are here after all), and also how some of us got to first hear of BVXP when the price was around £3. :) So... are we going to reach an all-time high this week?
Bioventix share price data is direct from the London Stock Exchange
ADVFN Advertorial
Your Recent History
LSE
BVXP
Bioventix
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20210726 02:47:18